Oncocross Co Ltd
382150
Company Profile
Business description
Oncocross Co Ltd is innovating the drug development process through its AI approach for developing treatments for cancers, rare diseases, and intractable diseases, thereby contributing to a healthier world. Its Technology platforms include ONCOCROSS AI Platform, RAPTOR AI, ONCO-RAPTOR AI, and ONCOfind AI.
Contact
Saechang-ro
11, 15, 16th floor
Mapo-gu
Seoul
KORT: +82 28679967
Sector
Technology
Stock type
Sensitive
Industry
Software - Infrastructure
Fiscal Year End
31 December 2025
Employees
31
Stocks News & Analysis
stocks
Insignia Financial: Revised deal still attractive
The offer price is well above our fair value.
stocks
Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?
With the monetization of GenAI, here’s what we think of Alphabet’s stock
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,985.10 | 43.60 | 0.49% |
| CAC 40 | 7,744.41 | 53.81 | -0.69% |
| DAX 40 | 24,041.90 | 265.90 | -1.09% |
| Dow JONES (US) | 44,502.44 | 179.37 | 0.40% |
| FTSE 100 | 9,023.81 | 10.82 | 0.12% |
| HKSE | 25,130.03 | 135.89 | 0.54% |
| NASDAQ | 20,892.69 | 81.49 | -0.39% |
| Nikkei 225 | 40,721.17 | 946.25 | 2.38% |
| NZX 50 Index | 12,756.49 | 77.25 | -0.60% |
| S&P 500 | 6,309.62 | 4.02 | 0.06% |
| S&P/ASX 200 | 8,721.50 | 44.30 | 0.51% |
| SSE Composite Index | 3,581.86 | 22.07 | 0.62% |